Cytomegalovirus antigenemina in idiopathic interstitial pneumonias and collagen vascular disease-related lung diseases treated with immunosuppressive drugs

T. Arai, Y. Inoue, K. Tachibana, J. Otsuka, K. Tsuyuguchi, S. Minamoto, M. Kitaichi, K. Suzuki, S. Hayashi, M. Oakada, M. Sakatani (Sakai City, Osaka, Japan)

Source: Annual Congress 2008 - Interstitial lung disease in systemic and vascular disorders
Session: Interstitial lung disease in systemic and vascular disorders
Session type: Thematic Poster Session
Number: 1884
Disease area: Interstitial lung diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
T. Arai, Y. Inoue, K. Tachibana, J. Otsuka, K. Tsuyuguchi, S. Minamoto, M. Kitaichi, K. Suzuki, S. Hayashi, M. Oakada, M. Sakatani (Sakai City, Osaka, Japan). Cytomegalovirus antigenemina in idiopathic interstitial pneumonias and collagen vascular disease-related lung diseases treated with immunosuppressive drugs. Eur Respir J 2008; 32: Suppl. 52, 1884

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Rituximab in the management of idiopathic inflammatory myopathies complicated by interstitial lung disease
Source: International Congress 2017 – The spectrum of CTDs: from pathogenesis to treatment
Year: 2017

Idiopathic nonspecific interstitial pneumonia: an interstitial lung disease associated with autoimmune disorders?
Source: Eur Respir J 2011; 38: 384-391
Year: 2011



Cyclophosphamide and low-dose prednisolone in idiopathic pulmonary fibrosis and fibrosing nonspecific interstitial pneumonia
Source: Eur Respir J 2005; 25: 528-533
Year: 2005



Occult connective tissue diseases mimicking idiopathic interstitial pneumonias
Source: Eur Respir J 2008; 31: 11-20
Year: 2008



Clinical efficacy of pirfenidone in patients with severe fibrosing interstitial pneumonia
Source: International Congress 2015 – Treatment of IPF
Year: 2015


Interstitial lung disease with autoimmune features
Source: Eur Respir Mon 2011; 54: 104-117
Year: 2011


Novel markers of connective tissue disease in patients with idiopathic interstitial pneumonia
Source: Annual Congress 2008 - Interstitial lung disease in systemic and vascular disorders
Year: 2008

Cyclosporine A in the treatment of idiopathic pulmonary fibrosis/usual interstitial pneumonia
Source: Eur Respir J 2002; 20: Suppl. 38, 62s
Year: 2002

Clinical features of usual interstitial pneumonia-correlation between idiopathic pulmonary fibrosis and connective tissue disease associated with usual interstitial pneumonia
Source: International Congress 2016 – Connective tissue disorders
Year: 2016

Severe interstitial lung disease in connective tissue disease: rituximab as rescue therapy},
Source: Eur Respir J 2012; 40: 641-648
Year: 2012



Antifibrotic treatment in progressive non-IPF fibrotic interstitial lung diseases
Source: International Congress 2019 – The world of idiopathic pulmonary fibrosis
Year: 2019


Antifibrotic therapy for fibrotic lung disease beyond idiopathic pulmonary fibrosis
Source: Eur Respir Rev, 28 (153) 190022; 10.1183/16000617.0022-2019
Year: 2019



Experience with antifibrotics treatment in progressive interstitial lung diseases non-IPF
Source: Virtual Congress 2021 – Clinical evolution, management and outcomes of patients with rare diffuse parenchymal lung diseases
Year: 2021


Significance of connective tissue disease features in idiopathic interstitial pneumonia
Source: Eur Respir J 2012; 39: 661-668
Year: 2012



Fibrotic CTD and interstitial pneumonia with autoimmune features (IPAF): immunosuppressive or/and anti-fibrotic treatment?
Source: Virtual Congress 2020 – Rheumatology: understanding connective tissue disease in patients with interstitial lung disease
Year: 2020


Idiopathic interstitial pneumonia and connective tissue disorder-related interstitial lung disease
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 978-1-904097-51-8, page=170
Year: 2007

Treatment of progressive fibrosing interstitial lung diseases: a milestone in the management of interstitial lung diseases
Source: Eur Respir Rev, 28 (153) 190109; 10.1183/16000617.0109-2019
Year: 2019



The epidemiology of idiopathic pulmonary fibrosis and interstitial lung diseases at risk of a progressive-fibrosing phenotype
Source: Eur Respir Rev, 27 (150) 180077; 10.1183/16000617.0077-2018
Year: 2018



Clubbing in patients with fibrotic interstitial lung diseases
Source: International Congress 2017 – ILDs: clinical problems
Year: 2017

The efficacy of cyclosporine A in patients with clinicoradiologically diagnosed idiopathic nonspecific interstitial pneumonia
Source: International Congress 2014 – ILDs: connective tissue disease
Year: 2014